The purpose of this study is to evaluate the relative efficacy and safety of prophylactic heparin co-administration during Xigris infusion in the treatment of severe sepsis in the adult.

Official Title



Study Type


Study Design


Further Details

Study Start

Eligibility & Criteria

Inclusion Criteria- Must be at least 18 years old – Must have been diagnosed with severe sepsis – Indicated for treatment with Xigris Exclusion Criteria- Have allergies or bad reactions to heparin – Require high doses of heparin for treatment of condition – Need other blood thinning medications or anticoagulants – Weigh more than 135 kg (297 pounds) – Are a pregnant woman, or are breast feeding.

Total Enrolment

Contact Details

“There may be multiple sites in this clinical trial.” Telephone: 1-877-CTLILLY

All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.